Cluster 2 tumours featured higher rates of TP53 mutations and human epidermal growth factor-2 (HER2) amplifications (p < 0.001 and p < 0.01, respectively) and increased HER2 expression (p < 0.05) [25]. Here, ERBB2 is linked to neoplasm.